# Araknitek

**Type:** venture
**Status:** Draft
**Confidence:** Low
**Focus:** synthetic spider silk, biomaterials, advanced materials, university spinout
**Stage:** Unknown (founded 2012; current operational status unverified)
**Location:** Logan, UT
**Updated:** 2026-06-19
**Needs-reviewed:** 2026-06-19
**Hero:** https://picsum.photos/seed/araknitek-2026/1600/1100
**Relates:** cites [Official Website: Araknitek](araknitek-official-website.md)

## Summary

Araknitek appears to be a Utah State University spinout commercializing synthetic spider silk proteins developed in the Randy Lewis laboratory — one of the world's most prominent academic programs for recombinant spider silk research. The company was founded around 2012. Limited public information suggests it targets high-performance fibers, medical implant coatings, sutures, and composite materials. Current operational status is unverified.

## Impact

Spider silk offers an unusual combination of mechanical properties: greater tensile strength per unit weight than steel, higher elasticity than Kevlar, and natural biocompatibility. If synthetic spider silk can be produced at commercial scale, the implications span defense (body armor, lightweight composites), medicine (sutures, scaffold materials, drug delivery coatings), and high-performance textiles.

The Randy Lewis lab's science is well-regarded in the academic literature and represents decades of foundational research. Whether Araknitek specifically is the active commercialization vehicle for that science is unclear — readers should verify this before investing time in the company.

## What They Are Building

Available public information is thin. Araknitek appears to be building a platform for producing recombinant spider silk proteins using the USU Lewis lab's genetic and fermentation systems. Reported target applications include:

- High-performance structural fibers and composite materials
- Medical implant coatings and biodegradable sutures
- Three-dimensional-printed medical scaffolding materials

The core technical challenge is producing spider silk proteins in sufficient quantity and at low enough cost to compete with existing high-performance synthetics. Bolt Threads, a California company that raised over $200 million to commercialize similar technology, illustrates the difficulty: the science is real, but commercial-scale production has proven extremely hard.

## What They Need Now

Unknown. Given the company's age and uncertain operational status, it is not clear whether Araknitek is actively hiring, seeking investment, or pursuing partnerships. Readers interested in spider silk commercialization should verify the current status of the organization before making contact.

## Who Could Help

If active, the venture would likely benefit from advanced materials investors, DoD or NIH funding for medical and defense applications, contract manufacturing partners with fermentation expertise, and materials-science customers who can qualify new fiber inputs. The USU Randy Lewis lab is the primary intellectual anchor.

## Utah Context

Utah State University's Randy Lewis laboratory is one of the most cited academic programs in recombinant spider silk research. Logan, UT hosts USU's main campus. If Araknitek remains active, it represents a direct commercialization path from one of Utah's most distinctive advanced-materials research programs. The spider silk space has seen multiple well-funded attempts to cross from academic success to commercial production — the pattern of difficulty is sector-wide, not specific to USU.

## Evidence

- [Official Website: Araknitek](araknitek-official-website.md)

## See Also

## Open Questions

- Is Araknitek still operationally active as of 2026? The company was founded in 2012 and current status is unverified.
- Has the Randy Lewis lab created a newer or differently named commercialization vehicle that supersedes Araknitek?
- What is Araknitek's website URL, if it still maintains a public web presence?
- Has the company received any SBIR, STTR, or private funding since founding?
- Spider silk commercialization has been "five years away" for decades — what specific technical milestones distinguish Araknitek's approach, if any?
- The placeholder hero should be replaced with a cleared materials or lab photograph when rights are confirmed.